About Hamilton Apex
Hamilton Apex is a venture capital firm located in Solana Beach, United States. As of Aug 2004, Hamilton Apex has invested in 3 companies. It primarily invests in Series A round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and Enterprise Infrastructure. Most recently it participated in the $***** Series C round of Ceregene Overall, Hamilton Apex portfolio has seen 3 acquisitions, namely Santarus, Ceregene and Troika Networks. A lot of funds co-invest with Hamilton Apex, with names like SR One sharing a substantial percentage of its portfolio. Hamilton Apex has team of 1 people including 1 partners.Key Metrics
Hamilton Apex's List of All Investments
Hamilton Apex has a portfolio of 3 companies. Their most notable investments include Santarus and Ceregene.Their portfolio spans across and United States. They have invested in Life Sciences, High Tech, Enterprise Infrastructure and 1 other sectors, across stages such as Series A, Series C and 1 more. Here is the list of all investments by Hamilton Apex:1. Santarus
Santarus, a specialty biopharmaceutical company is focused on acquiring, developing and commercializing proprietary products with a focus on gastrointestinal diseases. Its products include Uceris, approved last year for treating ulcerative colitis, as well as the stomach acid-reducing combination pill Zegerid. But Santarus also have products that work on conditions outside the gastrointestinal tract. It has two oral treatments for Type 2 diabetes, Glumetza and Cycloset, and Fenoglide, used to lower high cholesterol.
Key facts about Santarus
- Founded Year: 1996
- Location: San Diego (United States)
- Annual Revenue: $100M - $500M as on Dec 31, 2012
- Stage: Acquired
- Total Funding till date: $51.4M
- Employee Count: 81 as on Aug 31, 2026
- Investors: Advent Life Sciences, Life Sciences Partners and 11 Others
- Latest Funding Round: Series D, May 22, 2003, $*****
- Highlight: Acquired
2. Ceregene
Develops AAV-based therapies for neurodegenerative and eye disorders. The company's lead candidate CERE-120 contains the gene for NTN which is delivered to the area of the brain degenerating in Parkinson’s disease, CERE-110 carries the gene for NGF used for Alzheimer’s disease, and CERE-130 is an Insulin-like growth factor used for amyotrophic lateral sclerosis.
Key facts about Ceregene
- Founded Year: 2001
- Location: San Diego (United States)
- Stage: Acquired
- Total Funding till date: $71.5M
- Employee Count: 3 as on Aug 31, 2026
- Investors: Investor Growth Capital, Investor and 5 Others
- Latest Funding Round: Series D, Nov 11, 2010, $*****
- Highlight: Acquired
Troika Networks is a provider of Network Storage platform. Its platform known as Accelera optimizes storage applications and provides flexibility in adding capabilities to the network through a policy based design. This claims to help enterprises to leverage better data management and protection solutions.
Key facts about Troika Networks
- Founded Year: 1998
- Location: Westlake Village (United States)
- Stage: Acquired
- Total Funding till date: $81.4M
- Employee Count: 6 as on Aug 31, 2026
- Investors: Anthem Venture Partners, New Enterprise Associates and 6 Others
- Latest Funding Round: Series B, Jul 14, 2005, $*****
- Highlight: Acquired
Hamilton Apex's Investments by Stage
Hamilton Apex has made 1 investment in Series A stage with an average round size of $13M, 1 investment in Series C stage with an average round size of $32M and 1 investment in Series D stage with an average round size of $51.4M.Stage of entry | No. of Investments |
|---|---|
Series A | 1 |
Series C | 1 |
Series D | 1 |
Note: We have considered here, only first round of investments
Hamilton Apex's Investments by Sector
Hamilton Apex has a diverse portfolio, with companies operating in the Life Sciences, Enterprise Applications, Enterprise Infrastructure and High Tech. Notably, it has invested in 2 Enterprise (B2B) companies, 2 Tech companies and 1 Software company.Sector | No. of Investments |
|---|---|
Life Sciences | 2 |
Enterprise Applications | 1 |
Enterprise Infrastructure | 1 |
High Tech | 1 |
Note: We have considered here, only first round of investments
Hamilton Apex's Investments by Geography
Hamilton Apex has made most investments in United States (3).Hamilton Apex's recent investments
Hamilton Apex has not made any investment in 2026 so far.Here are the most recent investments by Hamilton Apex:
Date | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Aug 05, 2004 | United States | Series C | 5154 | [+1] | |
May 29, 2003 | United States | Series A | 9685 | ||
May 22, 2003 | United States | Series D | 2150 | [+7] |
Acquired companies in Hamilton Apex's Portfolio
3 companies from Hamilton Apex's portfolio have been acquired. The most recent acquisition was Santarus in Nov 2013 by Salix Pharmaceuticals for $*****.Here are Hamilton Apex's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Nov 07, 2013 | May 22, 2003 | Series D | 3374 | |
Aug 26, 2013 | Aug 05, 2004 | Series C | 4939 | |
Oct 19, 2005 | May 29, 2003 | Series A | 2602 |
Team profile of Hamilton Apex
Hamilton Apex has a team of 1 member. Hamilton Apex's team does not sit on the board of any company as of now.Co-investors of Hamilton Apex
Over the past 23 years, 20 investors have co-invested in Hamilton Apex's portfolio companies. This includes only funds.
- Invested before Hamilton Apex: DFJ, Windward Ventures and 3 others have invested in rounds before Hamilton Apex. There is 1 company where DFJ has invested before Hamilton Apex and 1 company where Windward Ventures has invested before Hamilton Apex.
- Top Co-investors of Hamilton Apex: 11 investors entered a company along with Hamilton Apex. These include investors like SR One (1 company).
- Invested after Hamilton Apex: A total of 4 investors have invested in Hamilton Apex's portfolio after their investments. Top Investors include Investor (1 company), Hamilton BioVentures (1 company) and Cell Genesys (1 company).
